1/38
Looks like no tags are added yet.
Substance Use Disorder
A treatable mental disorder affecting a person's brain and behavior, leading to an inability to control the use of legal or illegal drugs, alcohol, or medications (graded as Mild: 2-3 indicators, Moderate: 3-4, Severe: 6+).
Addiction
The most severe form of substance use disorder
Tolerance
The diminishing responsiveness to a drug with repeated use, requiring increasingly larger doses to achieve the same initial high
Agonists
Drugs or chemicals that mimic or facilitate the action of a natural neurotransmitter at receptor sites.
Antagonists
Drugs or chemicals that block or impede the normal activity of a neurotransmitter at receptor sites.
Pharmacokinetics
The study of what the body does to a drug as it moves through the system (absorption, distribution, metabolism, and excretion).
Pharmacodynamics
The study of what a drug does to the body and brain biochemically and physiologically.
Reward Pathway (Mesolimbic Pathway)
The brain circuit running from the ventral tegmental area (VTA) to the nucleus accumbens and prefrontal cortex
Dopamine Surge Benchmarks (Rat Brains)
Research comparisons showing how much substances spike dopamine release above baseline: chocolate (55%), nicotine (150%), cocaine (225%), and Adderall/amphetamines (1,000%).
Psychoactive Drugs
Chemical substances capable of crossing the blood-brain barrier to alter brain chemistry, perception, mood, thinking, and behavior
Four Indicator Categories of Substance Use Disorder
The diagnostic clusters used to evaluate drug disorders: Diminished Control, Diminished Social Functioning, Hazardous Use, and Drug Action (tolerance and withdrawal).
Physical Dependence vs. Psychological Dependence
Physical dependence is a physiological adaptation marked by painful physical withdrawal symptoms when stopped
Withdrawal
The painful, uncomfortable physiological and psychological symptoms experienced when a physically dependent user abruptly stops or reduces intake of a drug.
Stages of Addiction
The three-step behavioral progression explaining why drug desire persists even when pleasure fades: (1) Activation of pleasure, (2) Associative learning (linking cues/places to pleasure), and (3) Incentive salience (drug cues become overwhelmingly appealing).
Incentive-Sensitization Theory
An addiction theory distinguishing between "liking" (pleasure) and "wanting" (craving)
Self-Quitting Factors
Research findings showing most people who quit addictions on their own succeed when they: (1) realize abuse interferes with core personal values, (2) develop confidence they can change, and (3) join a community reinforcement program.
Alcohol Expectancies
Cognitive beliefs that alcohol acts as a positive transforming agent, enhances social/physical pleasure, or reduces tension
Caffeine (Methylxanthine)
The world's most widely used stimulant
Deborah Franklin's Addiction Factors
Four interacting variables driving addiction: (1) the nature/speed of the drug itself, (2) biological/genetic metabolism, (3) psychological factors (depression, low self-esteem), and (4) barren social environments.
Teen Substance Abuse Risk Factors
Three key risk factors identified by the National Center of Addiction and Substance Abuse: high stress, frequent boredom, and having too much spending money (e.g., $50/week vs. $15/week allowance).
Models of Addiction
Eight explanatory frameworks for addiction: Moral Model, Defect in Character Model, Opponent-Process Model, Disease Model, Genetic Model, Cultural Model, Blended Model, and Thomas Szaz's Habit Model (viewing addiction as a chosen bad habit).
Neurology of Addiction (Homeostasis)
To maintain homeostasis during massive drug-induced dopamine floods, neurons decrease their number of dopamine receptors and shut down natural dopamine production, directly causing tolerance and withdrawal crashes.
Narcotics (Opiates)
Highly addictive depressant painkillers derived from the opium poppy flower (morphine, heroin, codeine, oxycodone, hydrocodone) that mimic endorphins, produce a dreamy euphoria, and can cause fatal respiratory depression.
Opioid Withdrawal ("Cold Turkey")
Severe, flu-like withdrawal symptoms (sweating, chills, muscle pain, nausea, diarrhea, and "goosebumps") triggered when stopping opioids, often managed clinically using the long-acting opiate Methadone.
Opioid Brain Circuitry Damage
Repeated opioid use hijacks the survival reward pathway (tricking the brain into treating the drug like food/water) and impairs the developing adolescent prefrontal cortex ("brake pedal"), leading to denial and compulsive drug-seeking.
Stimulants
Psychoactive drugs (cocaine, amphetamines, methamphetamine, nicotine, caffeine) that excite neural activity, increase epinephrine, dopamine, and norepinephrine, and elevate alertness, confidence, heart rate, and mood.
Amphetamines vs. Methylphenidate (Ritalin)
Prescribed ADHD stimulants
Methamphetamine
A potent, crystalline CNS stimulant ("meth," "ice," "crystal") derived from amphetamine
Nicotine
A rapid-acting tobacco stimulant (reaching the brain in 10 seconds when inhaled) that triggers adrenaline release, suppresses insulin, spikes limbic dopamine, and acts as both a stimulant and a sedative depending on dose and arousal.
Cocaine Rebound Effect
The sharp depressive crash and suicidal ideation following cocaine's short-lived dopamine euphoria, driving chronic users to keep taking the drug "just to feel normal."
Depressants
Psychoactive drugs (alcohol, barbiturates, benzodiazepines like Xanax, Valium, Rohypnol, and GHB) that calm neural activity, reduce stress and anxiety, and slow down central nervous system functions.
Psychedelics (Hallucinogens)
Plant-based and synthetic drugs (LSD, marijuana/THC, mescaline from peyote, psilocybin from mushrooms, ketamine, MDMA) that disrupt serotonin systems to alter perception, induce hallucinations, and cause depersonalization.
Hallucinogen Flashbacks and Amotivational Syndrome
Long-term hallucinogen risks including brief, unprovoked perceptual flashbacks weeks later and amotivational syndrome (apathy, poor judgment, and memory/concentration deficits).
Coping and Social Skills Training (CSST)
An individual skill-based addiction treatment rooted in social learning theory that teaches strategies to overcome interpersonal and environmental "skill deficits" without using substances.
Motivational Enhancement Treatments (MET)
A supportive, non-threatening therapy approach that encourages clients to reflect objectively on the personal consequences of their substance abuse to build internal motivation for change.
Community Reinforcement Approach (CRA) & Family Therapy
Relationship-based treatments involving spouses and family members to reshape the user's social environment, build coping skills, and eliminate abusive drinking patterns.
Twelve-Step Programs
Abstinence-oriented, spiritually based mutual support groups modeled on Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) that rely on peer support and "working the steps."
Medication-Assisted Alcoholism Treatments
FDA-approved medications for alcoholism including Disulfiram (which induces sickness if alcohol is consumed) and Naltrexone (which blocks opioid/reward receptors and shows higher effectiveness with fewer side effects).